Adiponectin: action, regulation and association to insulin sensitivity

Adiponectin: action, regulation and association to insulin sensitivity Adiponectin is a novel adipocyte‐specific protein, which, it has been suggested, plays a role in the development of insulin resistance and atherosclerosis. Although it circulates in high concentrations, adiponectin levels are lower in obese subjects than in lean subjects. Apart from negative correlations with measures of adiposity, adiponectin levels are also reduced in association with insulin resistance and type 2 diabetes. Visceral adiposity has been shown to be an independent negative predictor of adiponectin. Thus, most features of the metabolic syndrome's negative associations with adiponectin have been shown. Adiponectin levels seem to be reduced prior to the development of type 2 diabetes, and administration of adiponectin has been accompanied by lower plasma glucose levels as well as increased insulin sensitivity. Furthermore, reduced expression of adiponectin has been associated with some degree of insulin resistance in animal studies indicating a role for hypoadiponectinaemia in relation to insulin resistance. The primary mechanisms by which adiponectin enhance insulin sensitivity appears to be through increased fatty acid oxidation and inhibition of hepatic glucose production. Adiponectin levels are increased by thiazoledinedione treatment, and this effect might be important for the enhanced insulin sensitivity induced by thiazolidinediones. In contrast, adiponectin levels are reduced by pro‐inflammatory cytokines especially tumour necrosis factor‐α. In summary, adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obesity Reviews Wiley

Adiponectin: action, regulation and association to insulin sensitivity

Loading next page...
 
/lp/wiley/adiponectin-action-regulation-and-association-to-insulin-sensitivity-bsz1Qz0KRn
Publisher site
See Article on Publisher Site

Abstract

Adiponectin is a novel adipocyte‐specific protein, which, it has been suggested, plays a role in the development of insulin resistance and atherosclerosis. Although it circulates in high concentrations, adiponectin levels are lower in obese subjects than in lean subjects. Apart from negative correlations with measures of adiposity, adiponectin levels are also reduced in association with insulin resistance and type 2 diabetes. Visceral adiposity has been shown to be an independent negative predictor of adiponectin. Thus, most features of the metabolic syndrome's negative associations with adiponectin have been shown. Adiponectin levels seem to be reduced prior to the development of type 2 diabetes, and administration of adiponectin has been accompanied by lower plasma glucose levels as well as increased insulin sensitivity. Furthermore, reduced expression of adiponectin has been associated with some degree of insulin resistance in animal studies indicating a role for hypoadiponectinaemia in relation to insulin resistance. The primary mechanisms by which adiponectin enhance insulin sensitivity appears to be through increased fatty acid oxidation and inhibition of hepatic glucose production. Adiponectin levels are increased by thiazoledinedione treatment, and this effect might be important for the enhanced insulin sensitivity induced by thiazolidinediones. In contrast, adiponectin levels are reduced by pro‐inflammatory cytokines especially tumour necrosis factor‐α. In summary, adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.

Journal

Obesity ReviewsWiley

Published: Feb 1, 2005

Keywords: ; ;

References

  • Adipose tissue as an endocrine organ
    Ahima, RS; Flier, JS
  • Paradoxical decrease of an adipose‐specific protein, adiponectin, in obesity
    Arita, Y; Kihara, S; Ouchi, N; Takahashi, M; Maeda, K; Miyagawa, J; Hotta, K; Shimomura, I; Nakamura, T; Miyaoka, K; Kuriyama, H; Nishida, M; Yamashita, S; Okubo, K; Matsubara, K; Muraguchi, M; Ohmoto, Y; Funahashi, T; Matsuzawa, Y
  • Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
    Weyer, C; Funahashi, T; Tanaka, S; Hotta, K; Matsuzawa, Y; Pratley, RE; Tataranni, PA
  • Correlation of the adipocyte‐derived protein adiponectin with insulin resistance index and serum high‐density lipoprotein‐cholesterol, independent of body mass index, in the Japanese population
    Yamamoto, Y; Hirose, H; Saito, I; Tomita, M; Taniyama, M; Matsubara, K; Okazaki, Y; Ishii, T; Nishikai, K; Saruta, T
  • Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
    Hotta, K; Funahashi, T; Bodkin, NL; Ortmeyer, HK; Arita, Y; Hansen, BC; Matsuzawa, Y
  • Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns
    Gavrila, A; Peng, CK; Chan, JL; Mietus, JE; Goldberger, AL; Mantzoros, CS
  • Plasma Acylation‐Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
    Faraj, M; Havel, PJ; Phelis, S; Blank, D; Sniderman, AD; Cianflone, K
  • Interleukin‐6 induces cellular insulin resistance in hepatocytes
    Senn, JJ; Klover, PJ; Nowak, IA; Mooney, RA
  • Endocrine and carbohydrate responses to interleukin‐6 in vivo
    Stith, RD; Luo, J
  • PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose‐derived protein
    Maeda, N; Takahashi, M; Funahashi, T; Kihara, S; Nishizawa, H; Kishida, K; Nagaretani, H; Matsuda, M; Komuro, R; Ouchi, N; Kuriyama, H; Hotta, K; Nakamura, T; Shimomura, I; Matsuzawa, Y
  • Fat depot‐specific expression of adiponectin is impaired in Zucker fatty rats
    Altomonte, J; Harbaran, S; Richter, A; Dong, H
  • Adiponectin Expression From Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor‐alpha Expression
    Kern, PA; Di Gregorio, GB; Lu, T; Rassouli, N; Ranganathan, G
  • The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects
    Yu, JG; Javorschi, S; Hevener, AL; Kruszynska, YT; Norman, RA; Sinha, M; Olefsky, JM

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off